These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 9566468)

  • 1. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.
    Stinnett AA; Mullahy J
    Med Decis Making; 1998; 18(2 Suppl):S68-80. PubMed ID: 9566468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.
    Willan AR; O'Brien BJ
    Health Econ; 1996; 5(4):297-305. PubMed ID: 8880166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.
    Briggs AH; Wonderling DE; Mooney CZ
    Health Econ; 1997; 6(4):327-40. PubMed ID: 9285227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies.
    Zethraeus N; Johannesson M; Jönsson B; Löthgren M; Tambour M
    Pharmacoeconomics; 2003; 21(1):39-48. PubMed ID: 12484802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stochastic league tables: an application to diabetes interventions in the Netherlands.
    Hutubessy RC; Niessen LW; Dijkstra RF; Casparie TF; Rutten FF
    Health Econ; 2005 May; 14(5):445-55. PubMed ID: 15386648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A note on confidence intervals in cost-effectiveness analysis.
    Tambour M; Zethraeus N; Johannesson M
    Int J Technol Assess Health Care; 1998; 14(3):467-71. PubMed ID: 9780533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The handling of uncertainty in economic evaluations of health care strategies].
    Siani C; Moatti JP
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):255-76. PubMed ID: 12876511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Handling uncertainty when performing economic evaluation of healthcare interventions.
    Briggs AH; Gray AM
    Health Technol Assess; 1999; 3(2):1-134. PubMed ID: 10448202
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means.
    Stinnett AA; Paltiel AD
    Med Decis Making; 1997; 17(4):483-9. PubMed ID: 9343807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.
    Hernández MA; Vázquez-Polo FJ; González-Torre FJ; Bas EM
    Int J Technol Assess Health Care; 2009 Oct; 25(4):537-45. PubMed ID: 19845984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
    Briggs AH; O'Brien BJ; Blackhouse G
    Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.
    Nixon RM; Wonderling D; Grieve RD
    Health Econ; 2010 Mar; 19(3):316-33. PubMed ID: 19378353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane.
    Briggs A; Fenn P
    Health Econ; 1998 Dec; 7(8):723-40. PubMed ID: 9890333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bootstrapping: estimating confidence intervals for cost-effectiveness ratios.
    Campbell MK; Torgerson DJ
    QJM; 1999 Mar; 92(3):177-82. PubMed ID: 10326078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis for clinicians.
    Hill SR
    BMC Med; 2012 Feb; 10():10. PubMed ID: 22296610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results.
    Tambour M; Zethraeus N
    Health Econ; 1998 Mar; 7(2):143-7. PubMed ID: 9565170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored.
    Blackhouse G; Briggs AH; O'Brien BJ
    Med Decis Making; 2002; 22(2):173-7. PubMed ID: 11958499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health economic evaluation: important principles and methodology.
    Rudmik L; Drummond M
    Laryngoscope; 2013 Jun; 123(6):1341-7. PubMed ID: 23483522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.